ZYVERSA THERAPEUTICS INC(ZVSA)

盘后1.36-0.06-4.15%19:59 EST

1.42+0.07+5.19%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
暂无内容
公司概况
公司名称
ZYVERSA THERAPEUTICS INC
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.zyversa.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
ZyVersa Therapeutics, Inc.于2021年3月17日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，利用专有技术为具有高度未满足医疗需求的慢性肾病或炎症性疾病患者开发药物。
- 2024-11-14
  超过5%披露
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 2024-11-14
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-11-14
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2024-11-06
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-10-30
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-09-16
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-09-10
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-09-10
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-08-09
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2024-08-01
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-05-15
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2024-05-15
  [修订]年度报告
  Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
  Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
- 2024-04-25
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-04-17
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-03-25
  年度报告
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]